Research

Ticker Move of the Day: ON -12% after $7B Synaptics acquisition spooks investors

Support · 1 min read · Jun 26, 2026, 7:32 AM PT

ON Semiconductor (ON) plunged approximately 12% to around $110 in early trading after announcing a $7 billion all-stock acquisition of Synaptics late yesterday, its largest deal ever. The chipmaker will exchange 1.35 shares for each Synaptics share, representing a 19% premium and diluting existing shareholders by giving Synaptics investors 12% of the combined company. Investors balked at the hefty price tag and dilution for a company focused on human-machine interface chips rather than ON's core automotive and power markets. The deal comes amid broader tech weakness, with the Nasdaq futures down 1.5% as AI valuations face renewed scrutiny. Traders will watch whether ON can hold the $106 support level as the company defends its pivot into Edge AI and Physical AI applications.

Research

SK Hynix Soars 11% on $29.4B US ADR Listing Plan to Tap AI Chip Demand

Support · 1 min read · Jun 25, 2026, 7:32 AM PT

SK Hynix shares jumped 11% at Thursday's open in Seoul following the announcement of a $29.4 billion US ADR listing planned for June 24, 2026. The South Korean memory chipmaker aims to tap US investor demand for AI semiconductor plays. The listing would mark one of the largest ADR offerings by an Asian technology company. SK Hynix supplies high-bandwidth memory chips crucial for AI applications to major customers including Nvidia. The company sees the US listing as a way to better compete for capital amid the global AI chip race.

Research

Ticker Move of the Day: WEN +31% after CFO hire reunites Potbelly team amid meme surge

Support · 1 min read · Jun 24, 2026, 7:31 AM PT

Wendy's (WEN) rocketed approximately 31% in premarket trading to around $8.30 after announcing Steve Cirulis as CFO and chief strategy officer, reuniting him with CEO Bob Wright who worked together at Potbelly during its turnaround. The fast-food chain's shares had touched a 20-year low of $6.07 yesterday before the executive appointment sparked intense retail investor enthusiasm, with the stock becoming the second-most discussed ticker on Reddit trading forums. The combination of credible leadership catalyst and heavily shorted float created a powerful rally disconnected from the broader market selloff. Trading volume surged on speculation of both a short squeeze and potential take-private transaction, though analysts remain cautious with Stephens maintaining an Equal Weight rating and $8 price target. The S&P 500 futures point down 1.5% as tech stocks remain under pressure from semiconductor concerns and rate hike fears.

Research

Ticker Move of the Day: AMC -19% after $200M dilutive stock offering

Support · 1 min read · Jun 23, 2026, 7:54 AM PT

AMC Entertainment (AMC) tumbled approximately 19% in premarket trading to around $2.24 after announcing a $200 million registered direct offering of 95.25 million shares to institutional investors. The movie theater chain plans to use most of the proceeds to redeem $125.5 million of its 6.125% Senior Subordinated Notes due 2027, with the deal expected to close June 24. The offering compounds dilution concerns, coming just twelve days after AMC raised another $150 million through a similar share sale, and hitting investors just as the stock had reached its highest levels of 2026 following strong Toy Story 5 weekend box office numbers. The sharp selloff reflects broader tech weakness, with semiconductor stocks also under pressure as South Korean chip stocks triggered circuit breakers overnight. The cinema operator's persistent capital raises and hefty $7.3 billion debt load continue to weigh on sentiment despite improving theater attendance trends.

Research

Ticker Move of the Day: APGE +47% after AbbVie announces $10.9B acquisition

Support · 1 min read · Jun 22, 2026, 7:32 AM PT

Apogee Therapeutics (APGE) skyrocketed approximately 47% to around $134 in premarket trading Monday after AbbVie announced it will acquire the clinical-stage immunology biotech for $135.11 per share in an all-cash deal valued at $10.9 billion. The acquisition price represents a roughly 50% premium to Thursday's closing price and gives AbbVie access to Apogee's lead drug candidate zumilokibart, an experimental treatment for atopic dermatitis and asthma that could potentially compete with Regeneron's blockbuster Dupixent. The deal marks AbbVie's latest move to strengthen its immunology portfolio ahead of Humira's continuing biosimilar erosion, with the transaction expected to be accretive to earnings by 2032. Traders should watch for the shareholder vote and regulatory approvals, while monitoring whether other biotechs with late-stage immunology assets see sympathy bids. Broader markets traded mixed with the S&P 500 up 0.1% and Nasdaq flat as U.S.-Iran peace talks showed progress.

Research

Ticker Move of the Day: CAST +89% after Starlink Business reseller agreement

Support · 1 min read · Jun 19, 2026, 7:32 AM PT

FreeCast (CAST) surged approximately 89% to $9.76 on Thursday after announcing a reseller agreement to offer Starlink Business satellite broadband services alongside its streaming media platform. The deal allows the struggling microcap to bundle enterprise-grade connectivity with its Platform-as-a-Service solutions, targeting multifamily housing, hospitality, healthcare, and underserved rural markets. Despite the explosive move on nearly 61 million shares traded, FreeCast faces significant financial headwinds with just $93K in quarterly revenue, a $4.5 million quarterly loss, and management's going-concern warning about its ability to continue without additional capital. The Starlink announcement follows last week's expanded DIRECTV partnership, creating back-to-back catalysts that have driven extreme volatility in the heavily shorted stock. Broader markets closed higher Thursday with the Nasdaq up 1.91% and S&P 500 gaining 1.08% as tech stocks rallied ahead of today's Juneteenth holiday closure.

Research

Ticker Move of the Day: ACN -14% after Q3 revenue miss and lowered guidance

Support · 1 min read · Jun 18, 2026, 7:32 AM PT

Accenture (ACN) plummeted approximately 14% in premarket trading to around $134 after the IT consulting giant reported Q3 revenue of $18.72 billion that missed analyst expectations of $18.75 billion, while also cutting its full-year revenue growth guidance to 3-4% in local currency from the prior 3-5% range. Despite beating earnings with $3.80 EPS versus $3.71 expected, the company's new bookings of $19.32 billion declined 2% year-over-year, signaling weakening demand for consulting services amid enterprise AI uncertainty and federal business headwinds. The stock is on track for a seven-and-a-half-year low as investors fear the company is losing ground to AI-native competitors and struggling with its traditional transformation business. Markets are broadly higher today, with the S&P 500 up about 1% as investors digest the Fed's hawkish hold and Trump's signing of the Iran peace deal, but ACN's sharp decline highlights sector-specific challenges in legacy IT services.

Research

Ticker Move of the Day: NVDA +3.5% after $25B bond sale draws $85B in orders

Support · 1 min read · Jun 16, 2026, 7:32 AM PT

Nvidia (NVDA) surged 3.5% to around $212.45 in Monday trading after successfully completing a $25 billion bond offering that attracted overwhelming demand of $85 billion in orders, more than three times the offering size. The AI chip giant's first debt issuance since 2021 was initially targeted at $20 billion but was upsized due to strong investor appetite, with seven tranches ranging from 2 to 30-year maturities priced at spreads of just 20-65 basis points over Treasuries. The bond sale underscores continued institutional confidence in Nvidia's AI dominance even as the company trades at a $5.15 trillion market cap, with proceeds earmarked for refinancing existing debt and funding AI infrastructure expansion. Traders are watching whether the low-cost capital access can help Nvidia maintain its edge as hyperscaler AI capex is projected to hit $1 trillion in 2027, though some worry the debt raise signals higher capital intensity ahead. The broader market traded mixed with S&P futures up 0.1% as investors await this week's Fed meeting.

Research

Ticker Move of the Day: FOX -17% after $22B Roku deal dilutes shareholders

Support · 1 min read · Jun 15, 2026, 7:32 AM PT

Fox Corporation (FOX) tumbled 17% to around $49 in morning trading after announcing it will acquire Roku for $22 billion in a cash-and-stock deal that significantly dilutes existing shareholders. The media giant will pay $96 in cash and 0.9693 shares of Fox Class A common stock for each Roku share, valuing the streaming platform at $160 per share. The deal's partial stock funding and $12 billion bridge financing facility are pressuring shares as investors worry about dilution and increased leverage. Upon closing, existing Fox shareholders will own approximately 73% of the combined company while Roku shareholders will get 27%. Fox expects $400 million in annual cost synergies and the transaction to become accretive to free cash flow by the second full year after closing, though investors appear skeptical about execution risk in the highly competitive streaming market. The broader market rallied on U.S.-Iran peace deal optimism, with the S&P 500 up 1.49%, Nasdaq gaining 2.38%, and the Dow advancing 1.20%.

Research

Ticker Move of the Day: SPCX indicated +30% in historic $75B SpaceX IPO debut

Support · 1 min read · Jun 12, 2026, 7:31 AM PT

SpaceX (SPCX) is indicated to open around $174-176 in today's Nasdaq debut, roughly 30% above the $135 IPO price in what will be the largest public offering in history. The Elon Musk-led space company raised $75 billion at a $1.77 trillion valuation, instantly making it one of the world's largest public companies and bigger than Tesla on day one. Crypto perpetual futures tracking SpaceX have been trading around $172-176 on platforms like Hyperliquid, suggesting strong retail and institutional demand despite the hefty valuation at roughly 110x trailing revenue. The offering bundles Starlink's profitable satellite internet business with the xAI division housing Grok, creating immediate index inclusion debates given the company's massive market cap. Broader markets are tracking higher with S&P futures up 0.6% on Iran peace deal hopes, though tech shares remain under pressure with Adobe falling 7% after earnings.

Research

Ticker Move of the Day: INTC +5% after BofA double upgrade on foundry momentum

Support · 1 min read · Jun 11, 2026, 7:32 AM PT

Intel (INTC) surged 5% to $112.90 in Wednesday trading after Bank of America double-upgraded the chipmaker from Sell to Buy, citing increased visibility into its foundry business turnaround and recent major customer wins including a reported 3 million AI chip order from Google for 2028. The upgrade comes as Intel's stock has already rallied 168% year-to-date following six consecutive earnings beats and growing confidence in its 18A process node development, with analysts now expecting earnings per share to jump 159% this year. The move extends Intel's remarkable reversal from its August 2025 low of $18.97, though the stock pulled back to around $105 by day's end as broader semiconductor weakness and concerns about Oracle's AI infrastructure spending weighed on the sector. Traders are now watching Intel's July 22 earnings for further validation of the foundry strategy, with the stock's negative P/E ratio of -170 suggesting the market is still pricing in execution risk despite the recent operational improvements.

Research

Ticker Move of the Day: CBRL +10.7% after Q3 earnings surprise drives guidance raise

Support · 1 min read · Jun 10, 2026, 7:32 AM PT

Cracker Barrel (CBRL) surged 10.7% in premarket trading to around $41 after reporting third-quarter earnings that dramatically exceeded Wall Street expectations, with adjusted EPS of $0.29 versus the consensus loss of $0.48. The restaurant chain posted revenue of $797.4 million, beating estimates of $776.7 million, while adjusted EBITDA of $40.3 million crushed expectations of $23.5 million as cost management initiatives and loyalty program expansion to 12 million members drove improved margins. The company raised its fiscal 2026 revenue guidance to $3.29 billion at the midpoint, above analyst estimates of $3.25 billion, citing positive trends in menu optimization and operational efficiency despite ongoing headwinds from fuel inflation and lower-income consumer softness. The surprise profitability turnaround marks a sharp reversal for the struggling casual dining chain, which has faced years of declining traffic and margin pressure. Broader markets remained under pressure with S&P 500 futures down about 0.5% amid escalating U.S.-Iran tensions pushing oil prices higher.

Research

Ticker Move of the Day: APLD +11.5% after third hyperscaler lease for AI data center

Support · 1 min read · Jun 09, 2026, 7:32 AM PT

Applied Digital (APLD) surged 11.5% to $45.66 in premarket trading Tuesday after announcing its third 15-year lease agreement with the same U.S.-based investment-grade hyperscaler for its Delta Forge 2 AI Factory campus. The deal adds approximately $5.2 billion in contracted revenue during the base term, potentially reaching $12.7 billion if renewed, bringing the company's total contracted lease revenue to $36 billion base or $86 billion with all options exercised. The announcement comes just a day after Applied Digital secured up to $550 million in new capital to accelerate its AI infrastructure buildout, with CEO Wes Cummins calling the continued demand "strong validation" of their integrated model of design, construction, and operations expertise. About 70% of the company's contracted revenue is now backed by U.S.-based investment-grade hyperscalers, significantly de-risking its customer base as AI data center demand continues to explode. Markets broadly rose with the S&P 500 up 0.55% and Nasdaq gaining 1.14% as chip stocks rebounded from Friday's selloff.

Research

Ticker Move of the Day: LLY +3.9% after obesity drug data impresses at diabetes conference

Support · 1 min read · Jun 08, 2026, 7:32 AM PT

Eli Lilly (LLY) surged 3.9% to $1,178 in premarket trading after showcasing compelling Phase 3 data for its oral GLP-1 drug Foundayo at the American Diabetes Association's 86th Scientific Sessions, demonstrating superior A1C reduction and weight loss versus rival treatments. The pharma giant also presented positive results for its triple-hormone receptor agonist retatrutide, showing substantial improvements in knee osteoarthritis pain and sleep apnea alongside weight loss, bolstering confidence in its obesity pipeline worth an estimated $100+ billion market opportunity. Citi analysts called Lilly's incretin portfolio "category-defining" while Bank of America raised its price target to $1,251, noting the data positions Lilly to maintain its 60% market share in the rapidly expanding GLP-1 space. The stock's resilience stands out as broader markets recover modestly from Friday's tech-led selloff, with the S&P 500 futures up 0.7%. Traders are watching for CVS Caremark's expanded coverage of Lilly's obesity drugs starting this month, which could accelerate prescription volumes heading into the company's August 5 earnings report.

Research

Ticker Move of the Day: LULU -13% after guidance cut on weak North America sales

Support · 1 min read · Jun 05, 2026, 7:32 AM PT

Lululemon Athletica (LULU) plunged 13% to $110 Friday after slashing its full-year profit forecast and warning of deteriorating conditions in its core North American market following Q1 earnings. The athleisure retailer cut fiscal 2026 revenue guidance to $11-11.15 billion from $11.35-11.5 billion, with earnings per share now expected at $10.95-11.15 versus previous guidance of $12.10-12.30, as interim CEO Meghan Frank blamed negative media commentary and disappointing product launches. Despite beating Q1 expectations with revenue of $2.47 billion and EPS of $1.69, gross margins fell 410 basis points to 54.2% due to tariff impacts, while Americas comparable sales declined 5% for the fifth straight quarter. The stock, already down 40% year-to-date before today's drop, faces continued pressure as management expects North America sales to fall by double-digits in Q2 ahead of new CEO Heidi O'Neill's arrival in September. Markets showed resilience elsewhere, with the Dow gaining 875 points Thursday to a record high on financial sector rotation, though tech weakness persisted following Broadcom's AI guidance disappointment.

Research

Ticker Move of the Day: AVGO -15% after AI chip guidance misses lofty expectations

Support · 1 min read · Jun 04, 2026, 7:32 AM PT

Broadcom (AVGO) plunged 15% to $407 Thursday, marking its biggest one-day drop since January 2025, after the custom chip designer's Q3 AI semiconductor revenue outlook of $16 billion fell short of analysts' expectations of $17.2 billion. The company reported strong Q2 results with AI chip revenue soaring 143% year-over-year to $10.8 billion and total revenue hitting $22.2 billion, but CEO Hock Tan's decision not to raise the full-year $100 billion AI revenue target spooked investors who had bid the stock up 40% year-to-date. The selloff dragged down the broader semiconductor sector, with the Nasdaq falling 0.76% as traders reassessed the sustainability of the AI-driven chip rally that has powered markets to records. The stark reaction underscores how priced-for-perfection AI stocks face harsh punishment for even modest guidance misses, with Broadcom's 4-for-1 stock split announcement and raised Q3 revenue forecast of $29.4 billion providing little cushion against disappointment.

Research

Ticker Move of the Day: MRVL +32% after Jensen Huang calls it 'next trillion-dollar company'

Support · 1 min read · Jun 03, 2026, 7:32 AM PT

Marvell Technology (MRVL) soared 32.5% Tuesday, marking its biggest one-day gain ever, after Nvidia CEO Jensen Huang labeled it the 'next trillion-dollar company' at Computex in Taipei. Huang praised Marvell's essential role in AI infrastructure, highlighting how its networking and connectivity chips enable data centers to distribute computing tasks across thousands of connected processors. The endorsement builds on Nvidia's recent $2 billion investment in Marvell and comes as the chipmaker projects its custom silicon business will exceed $10 billion in annual revenue by fiscal 2029. At Tuesday's close of roughly $250 billion market cap, Marvell would need to quadruple to reach Huang's trillion-dollar target, but traders are betting on accelerating AI demand for optical interconnects and high-speed switching. Markets closed mixed Wednesday with the S&P 500 down 0.2% as oil prices climbed on Middle East tensions.

Research

Ticker Move of the Day: MRVL +23.8% after Nvidia CEO calls it 'next trillion-dollar company'

Support · 1 min read · Jun 02, 2026, 8:05 AM PT

Marvell Technology (MRVL) surged 23.8% to $268 after Nvidia CEO Jensen Huang proclaimed it the 'next trillion-dollar company' at Computex, highlighting its critical role in AI data center infrastructure. The endorsement came as Marvell unveiled its groundbreaking 102.4 Tbps Teralynx T100 switch, the industry's first purpose-built for AI workloads, offering 25% lower power consumption than competitors while addressing GPU utilization bottlenecks. The surge follows Marvell's recent projection that its custom chip business could generate over $10 billion annually by fiscal 2029, with data center revenue now comprising 75% of total revenue versus 50% two years ago. Reaching Huang's trillion-dollar target would require a 400% gain from current levels, but with Nvidia having invested $2 billion in Marvell and AI infrastructure demand accelerating, traders are watching for sustained momentum as the T100 begins sampling this quarter. The broader market traded mixed, with the S&P 500 up 0.05% and tech leading amid renewed AI optimism.

Research

Ticker Move of the Day: TMHC +22% on Berkshire Hathaway's $6.8B buyout

Support · 1 min read · Jun 02, 2026, 7:31 AM PT

Taylor Morrison (TMHC) shares surged 22% in premarket trading after Berkshire Hathaway announced it would acquire the homebuilder for $72.50 per share in an all-cash deal worth $6.8 billion. The offer represents a 24% premium to TMHC's Friday close, marking Greg Abel's first major acquisition since becoming Berkshire CEO and signaling renewed confidence in the US housing market. The deal values Taylor Morrison at approximately $8.5 billion including debt, with closing expected in the second half of 2026 pending shareholder and regulatory approval. Traders are watching whether the acquisition sparks further consolidation in homebuilders and how Abel's strategy differs from Buffett's approach. The broader market opened mixed, with the S&P 500 down 0.14% and tech names like HPE rallying over 25% on strong AI-driven earnings.

Research

Ticker Move of the Day: TMHC +22% after Berkshire Hathaway acquisition

Support · 1 min read · Jun 01, 2026, 7:31 AM PT

Taylor Morrison (TMHC) surged 22.3% in premarket trading after Berkshire Hathaway announced it will acquire the homebuilder for $72.50 per share in an all-cash deal worth $8.5 billion in enterprise value. The offer represents a 24% premium to TMHC's $58.50 closing price, marking Greg Abel's first major acquisition since becoming Berkshire CEO and signaling confidence in U.S. housing despite elevated mortgage rates. The deal values TMHC at approximately $6.8 billion in equity, with the transaction expected to close in H2 2026 pending shareholder and regulatory approvals. Upon completion, Taylor Morrison will become a private company under existing management, expanding Berkshire's housing portfolio alongside Clayton Homes. Broader markets showed mixed sentiment, with the S&P 500 up 0.22% and oil climbing 7% on renewed Iran tensions.